Eligibility for Noninvasive Testing Based on the 2021 American Heart Association/American College of Cardiology Guideline for the Evaluation and Diagnosis of Stable Chest Pain: Implications From the PROMISE Trial

August 15, 2022

By Hannah Branch

Homepage
>
Publications
>
Eligibility for Noninvasive Testing Based on the 2021 American Heart Association/American College of Cardiology Guideline for the Evaluation and Diagnosis of Stable Chest Pain: Implications From the PROMISE Trial

Fordyce CB, Hill CL, Foldyna B, Douglas PS; on behalf of the PROMISE Investigators

Comments are closed.